Cognitive Training for Mild Cognitive Impairment
Trial Summary
What is the purpose of this trial?
This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitive rehabilitation manualized intervention for older adults with MCI, with a focus on the impact of stress on cognitive functioning; that integrates components from the Race Based Stress and Empowerment (RBSE) group for an increased focus on race-based stress and discrimination for racial minority older adults (i.e., RBSEF-CCT-MCI). In a pilot open trial, 75-150 participants will receive group-based intervention for 8 weeks, with 8-10 participants per group. Following the pilot study, the investigators will complete a randomized controlled trial (RCT) (Phase 2) to compare the efficacy of the RBSEF-CCT-MCI with the ME-CCT. In the RCT, 75-150 participants will be randomized into either 1) The active control group, who will complete the original, ME-CCT training program, or 2) The experimental group, who will complete the newly developed RBSE-CCT-MCI. Both research groups will complete the interventions for 8 weeks, with 8-10 participants per group. Hypothesis: Participation in this newly developed/updated intervention (i.e., RBSEF-CCT-MCI) will result in improvements in both (a) subjective and (b) objective cognitive functioning, and (c) self-reported mental health symptoms.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT) and Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI)?
Research shows that cognitive training programs can help improve cognitive processing speed in people with mild cognitive impairment (MCI), with benefits lasting up to five years. This suggests that similar cognitive training treatments like ME-CCT and RBSEF-CCT-MCI might also be effective in maintaining cognitive function.12345
Is cognitive training safe for people with mild cognitive impairment?
How is the RBSEF-CCT-MCI treatment different from other treatments for mild cognitive impairment?
Research Team
Rachael L Ellison, PhD
Principal Investigator
Rosalind Franklin University of Medicine and Science
Eligibility Criteria
This trial is for older adults with mild cognitive impairment (MCI), particularly those from racial minority groups who may experience race-based stress and discrimination. Participants should be interested in group-based interventions aimed at improving cognitive functioning and mental health.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pilot Intervention
Participants receive group-based intervention for 8 weeks focusing on race-based stress and cognitive training
Randomized Controlled Trial (RCT)
Participants are randomized to either the active control group (ME-CCT) or the experimental group (RBSEF-CCT-MCI) for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT)
- Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rosalind Franklin University of Medicine and Science
Lead Sponsor